GlassScriptPhysician profile
Jordan Etscheidt
NPI 1568873446
$10,914.09
in general payments reported to CMS, 2019-2025
9 companies · $463 in 2025
The $463 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $661 · 2020: $7,246 · 2021: $125 · 2022: $1,884 · 2023: $456 · 2024: $78.03 · 2025: $463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $997.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $4,617.52 | 2020-2025 | Real Intelligence, Pico, Redapt |
| Stryker Corporation | $3,540.08 | 2019-2025 | Triathlon, Mako, Monterey Al |
| Encore Medical, LP | $1,527.73 | 2020 | |
| Zimmer Biomet Holdings, INC. | $876.61 | 2019-2020 | |
| Depuy Synthes Sales INC. | $149.44 | 2023 | Velys, Actis |
| Medacta USA, INC. | $142.40 | 2023 | Gmk Sphere |
| Bioventus LLC | $22.04 | 2025 | Exogen Ultrasound Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $19.55 | 2025 | |
| Pacira Therapeutics, INC. | $18.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Etscheidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.